Glucocorticoids antagonize insulin's antiproteolytic action on skeletal muscle in humans
Although chronic glucocorticoid elevations cause net skeletal muscle protein loss in man, the kinetic mechanisms responsible for this catabolic effect and the capacity of insulin to overcome it remain unclear. To examine this issue, we measured basal and insulin-stimulated rates of protein synthesis...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 79; no. 1; p. 278 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.07.1994
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Although chronic glucocorticoid elevations cause net skeletal muscle protein loss in man, the kinetic mechanisms responsible for this catabolic effect and the capacity of insulin to overcome it remain unclear. To examine this issue, we measured basal and insulin-stimulated rates of protein synthesis and breakdown in muscle using the phenylalanine forearm kinetic method in eight normal volunteers studied postabsorptively and after 4 days of dexamethasone treatment (8 mg/day). To avoid the confounding effects of systemic insulinization, local forearm insulin levels were raised by approximately 430 pmol/L using a 150-min brachial arterial infusion of insulin (0.251 pmol/kg.min). Postabsorptively, dexamethasone produced mild hyperglycemia (P < 0.003) and a 3-fold rise in plasma insulin (P < 0.001), but no change in forearm phenylalanine balance or kinetics. Before dexamethasone treatment, local hyperinsulinemia increased forearm glucose uptake 2.5-fold and caused a positive net balance of phenylalanine due to a marked 40% inhibition of proteolysis. After dexamethasone treatment, forearm glucose uptake was modestly reduced. However, forearm net phenylalanine balance remained negative due to a striking reduction in insulin's inhibitory effect on proteolysis. We conclude that 1) the effects of glucocorticoid on basal muscle protein turnover are minimized by compensatory hyperinsulinemia, and 2) glucocorticoids cause muscle resistance to insulin's antiproteolytic action. |
---|---|
AbstractList | Although chronic glucocorticoid elevations cause net skeletal muscle protein loss in man, the kinetic mechanisms responsible for this catabolic effect and the capacity of insulin to overcome it remain unclear. To examine this issue, we measured basal and insulin-stimulated rates of protein synthesis and breakdown in muscle using the phenylalanine forearm kinetic method in eight normal volunteers studied postabsorptively and after 4 days of dexamethasone treatment (8 mg/day). To avoid the confounding effects of systemic insulinization, local forearm insulin levels were raised by approximately 430 pmol/L using a 150-min brachial arterial infusion of insulin (0.251 pmol/kg.min). Postabsorptively, dexamethasone produced mild hyperglycemia (P < 0.003) and a 3-fold rise in plasma insulin (P < 0.001), but no change in forearm phenylalanine balance or kinetics. Before dexamethasone treatment, local hyperinsulinemia increased forearm glucose uptake 2.5-fold and caused a positive net balance of phenylalanine due to a marked 40% inhibition of proteolysis. After dexamethasone treatment, forearm glucose uptake was modestly reduced. However, forearm net phenylalanine balance remained negative due to a striking reduction in insulin's inhibitory effect on proteolysis. We conclude that 1) the effects of glucocorticoid on basal muscle protein turnover are minimized by compensatory hyperinsulinemia, and 2) glucocorticoids cause muscle resistance to insulin's antiproteolytic action. |
Author | Sherwin, R S Louard, R J Barrett, E J Bhushan, R Gelfand, R A |
Author_xml | – sequence: 1 givenname: R J surname: Louard fullname: Louard, R J organization: Yale General Clinical Research Center, Yale University School of Medicine, New Haven, Connecticut 06510 – sequence: 2 givenname: R surname: Bhushan fullname: Bhushan, R – sequence: 3 givenname: R A surname: Gelfand fullname: Gelfand, R A – sequence: 4 givenname: E J surname: Barrett fullname: Barrett, E J – sequence: 5 givenname: R S surname: Sherwin fullname: Sherwin, R S |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8027242$$D View this record in MEDLINE/PubMed |
BookMark | eNotj8FLwzAYxXOYzG168izk5qk1-dIs7VGGTmHgRWG3kX5NNDNNStMe5l9v1cGDB4_3e_CWZBZiMITccJZz4Oz-iLmqcp6DKmdkwRjwrFKwvyTLlI6M8aKQYk7mJQMFBSzIfutHjBj7wWF0TaI6DPojBvdtqAtp9C7c_YWu6-Ngoj9NRapxcDHQSenLeDNoT9sxof9l6OfY6pCuyIXVPpnrs6_I-9Pj2-Y5271uXzYPuwxFKYasRsWsQcGtrUEWay6ENDVgIaCRjKEFoY1sQHBQlRKopVwz5LYxE8F5Ayty-7_bjXVrmkPXu1b3p8P5IfwAe91UIw |
CitedBy_id | crossref_primary_10_1111_j_1651_2227_1999_tb14362_x crossref_primary_10_1113_JP270737 crossref_primary_10_1113_jphysiol_2002_032367 crossref_primary_10_1016_S1096_6374_02_00022_9 crossref_primary_10_1146_annurev_nutr_17_1_457 crossref_primary_10_1016_j_metabol_2005_11_011 crossref_primary_10_1203_PDR_0b013e318123f72f crossref_primary_10_1016_S0026_0495_96_90120_1 crossref_primary_10_1046_j_1365_2362_2002_00993_x crossref_primary_10_1124_jpet_109_162487 crossref_primary_10_1046_j_1365_201X_1998_00306_x |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1210/jc.79.1.278 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 8027242 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: DK-38578 – fundername: NCRR NIH HHS grantid: RR-00125 – fundername: NIDDK NIH HHS grantid: DK-20495 |
GroupedDBID | --- -~X .55 .GJ .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 3O- 3V. 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAJQQ AAKAS AAPGJ AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL AAYJJ ABBLC ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABSAR ABWST ABXVV ACFRR ACGFO ACGFS ACPRK ACUTJ ACYHN ACZBC ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK ADZCM AELWJ AEMDU AENEX AENZO AERZD AETBJ AEWNT AFCHL AFFNX AFFZL AFGWE AFOFC AFRAH AFXAL AFYAG AGINJ AGKRT AGMDO AGQXC AGUTN AHMBA AI. AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT APJGH AQDSO AQKUS ARIXL ASPBG ATGXG AVNTJ AVWKF AZFZN BAWUL BAYMD BCRHZ BENPR BEYMZ BPHCQ BSWAC BTRTY BVXVI C45 CDBKE CGR CS3 CUY CVF D-I DAKXR DIK E3Z EBS ECM EIF EIHJH EJD EMOBN ENERS F5P FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK G8K GAUVT GJXCC GX1 H13 HVGLF HZ~ H~9 IAO IHR INH ITC J5H KBUDW KOP KQ8 KSI KSN L7B M5~ MBLQV MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NPM NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G PQQKQ PROAC REU ROX ROZ TEORI TJX TLC TMA TR2 TWZ VH1 VVN W8F WHG WOQ X52 X7M YBU YFH YHG YOC YSK ZGI ZXP ZY1 ~02 ~H1 |
ID | FETCH-LOGICAL-c383t-bc70fec31ffb25461335eb2c432d500cf23ae5d23127973ca5560c1fde1ff11d2 |
ISSN | 0021-972X |
IngestDate | Sat Sep 28 07:32:55 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c383t-bc70fec31ffb25461335eb2c432d500cf23ae5d23127973ca5560c1fde1ff11d2 |
PMID | 8027242 |
ParticipantIDs | pubmed_primary_8027242 |
PublicationCentury | 1900 |
PublicationDate | 1994-07-01 |
PublicationDateYYYYMMDD | 1994-07-01 |
PublicationDate_xml | – month: 07 year: 1994 text: 1994-07-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 1994 |
SSID | ssj0014453 |
Score | 1.6911396 |
Snippet | Although chronic glucocorticoid elevations cause net skeletal muscle protein loss in man, the kinetic mechanisms responsible for this catabolic effect and the... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 278 |
SubjectTerms | Adolescent Adult Amino Acids - blood Blood Glucose - metabolism Dexamethasone - pharmacology Female Forearm - blood supply Glucagon - blood Humans Hydrocortisone - blood Insulin - blood Insulin - pharmacology Insulin Antagonists - pharmacology Kinetics Lactates - blood Lactic Acid Male Muscle Proteins - metabolism Muscles - drug effects Muscles - metabolism Phenylalanine - blood Protease Inhibitors - pharmacology |
Title | Glucocorticoids antagonize insulin's antiproteolytic action on skeletal muscle in humans |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8027242 |
Volume | 79 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEF4FKhCXqoUiSqHyoRInR_HuOnaOLeIhJDggkHJD3peISOxISQ7wB_q3-fYR26QFtUiWY-16V4nny3hn9psZQn5IhncQNTyWhaExN1ka51pBILQ_UGne6wvn0L-86p_f8othOux0frdYS4u56Mqnv8aVvEeqaINcbZTsf0i2nhQNuIZ8cYaEcf4nGZ9ZvjnMR3RUI2WzLds9pnL0pJccc-eOR_PI5WOoxo8uP6svD45j9oC3jg2HnCxmmNs6P1zRvll7zWqR1EowUcdS6lJV0Dllk8VpgrlENV5mJbQ8n2pRePL8dbMB9et-MbsP-081_0ePTeBYXrf9qzWR-CSMVyFkj9ds1iZiIIkHmSubXmtdX0LmBbqCCvUlff5Q7bBNrWqX3WzQhWH_8i7IZTpxUs5hZ1OfsOvNzpUs26FnjaxluVWUV9bpEzajOA_JTMPPCGGeNvip9XW2yEaYZMVCcSuVm0_kYzAxop8eL59JR5fbZPMykCh2yHAFNlEDmyjA5sg1tkETedBEOJagiTxoMCbyoPlCbk9Pbo7P41BgI5YsZ_NYyKxntGSJMcLWRUgYS7WgkjOq0l5PGsoKnSqYADQbZEwWKdbHMjFKY0SSKLpL1suq1HskkpLifi4l1ve8UHkuLMkXn4kwMCrUV7Lrn8nd1GdRuQsPa_-1jm9kqwHTAflg8KfVh1gBzsV3J59ntcReFQ |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glucocorticoids+antagonize+insulin%27s+antiproteolytic+action+on+skeletal+muscle+in+humans&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Louard%2C+R+J&rft.au=Bhushan%2C+R&rft.au=Gelfand%2C+R+A&rft.au=Barrett%2C+E+J&rft.date=1994-07-01&rft.issn=0021-972X&rft.volume=79&rft.issue=1&rft.spage=278&rft_id=info:doi/10.1210%2Fjc.79.1.278&rft_id=info%3Apmid%2F8027242&rft_id=info%3Apmid%2F8027242&rft.externalDocID=8027242 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |